Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
Recruiting now · Not applicable
Conditions studied: Anxiety, Mild Cognitive Impairment, Alzheimer Disease, Dementia
In brief
The goal of this clinical trial is to test the effectiveness of a computerized anxiety sensitivity treatment (CAST) compared to a health education control (HEC) in older adults with mild cognitive impairment (MCI) or mild Alzheimer's Disease and related dementias (ADRD) and their care partners. The main questions it aims to answer are: 1. Efficacy of CAST in reducing anxiety and related symptoms among those with MCI/mild ADRD 2. Efficacy of CAST in reducing care partner burden among care partners of people living with MCI/mild ADRD 3. Explore treatment mechanisms using a multi-modal assessment battery of anxiety sensitivity and anxiety Participants will complete six in-person visits including a baseline assessment, two intervention sessions, and three follow-up assessments at 1, 3, and 6-months posttreatment. Participants will also complete three weeks of ecological momentary assessments (EMAs) for one week prior to intervention, one week between intervention sessions, and one week after intervention. If there is a comparison group: Researchers will compare CAST to HEC to see if CAST reduces anxiety and related symptoms in older adults with MCI/mild ADRD and care partner burden to a greater degree than HEC.
Key facts
- Study ID
- NCT05748613
- Run by
- Florida State University
- People needed
- 388
- Starts
- 2023-11-02
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-03-05
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- DYAD
- Patient age 60+
- Care partner 18+
- Has care partner who will participate ("someone you have a reciprocal relationship with who provides you with emotional or physical support and helps with decision-making. This could be a spouse or significant other, relative, or close friend whom you spend a significant amount of time with.")
- Has smartphone or access to Wi-Fi
- EITHER
- Score of 20 or above on the PROMIS-Anxiety short form (patient only) OR
- Score of 5 or above on SSASI (patient only) OR
- Score of 31 or above on NIH Toolbox Perceived Stress Scale score (patient only)
- AND EITHER
- Participant MoCA score is between 17 to 26
- OR
- Participant Memory Complaint Scale score 3 or greater
- OR
- Care partner quick dementia rating scale score between 2 to 12.5
You may not qualify if…
- PATIENT
- Issues with seeing or hearing that would prevent reading or listening to computer presentations
- Medical conditions that would preclude participation in study
- Severe mental illness (e.g., schizophrenia, unmedicated bipolar disorder)
- CARE PARTNER
- Issues with seeing or hearing that would prevent reading or listening to computer presentations
- Medical conditions that would preclude participation in study
- Severe mental illness (e.g., schizophrenia, unmedicated bipolar disorder)
Where it is running
- Anxiety and Behavioral Health Clinic — Tallahassee, Florida, United States (enrolling)
- Ohio University — Athens, Ohio, United States (enrolling)
- The Ohio State University — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.